Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

81. Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women

Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women | Evidence-Based Nursing This site uses cookies. By continuing to browse (...) intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Article Text Therapeutics Randomised controlled trial A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Maggi Banning Statistics from Altmetric.com No Altmetric data available for this article

Evidence-Based Nursing (Requires free registration)2010

82. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of screening for breast cancer, using magnetic resonance imaging (MRI), screen-film mammography, or both, for women with mutations of the breast cancer gene BRCA1. The authors concluded that annual mammography and MRI detected

NHS Economic Evaluation Database.2010

83. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF.

Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. | Clinical Correlations Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. November 17, 2009 Aalok Turakhia, MD As the debate over when to begin screening mammography in women rages on, the United States Prevention Service Task Force (USPSTF) added fuel to the fire by releasing a new recommendation statement in the November (...) 17th issue of the Annals of Internal Medicine. Applying to women aged ≥40 who are not at an increased genetic risk or have had chest irradiation, the USPSTF now recommends biennial screening in women between ages 50-74. In February 2002, the task force first recommended that annual or biennial screening start at age 40; however, in a revised statement, “The USPSTF recommends against routine screening mammography in women aged 40 to 49 years.” It adds, “The decision to start regular, biennial

Clinical Correlations2009

84. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms.

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. BACKGROUND: Despite trials of mammography and widespread use, optimal screening policy is controversial. OBJECTIVE: To evaluate U.S. breast cancer screening strategies. DESIGN: 6 models using common data elements. DATA SOURCES: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. TARGET POPULATION: A contemporary

Annals of Internal Medicine2009 Full Text: Link to full Text with Trip Pro

85. A meta-analysis of interventions to promote mammography among ethnic minority women

A meta-analysis of interventions to promote mammography among ethnic minority women 19609176 2009 07 17 2009 08 11 2016 11 22 1538-9847 58 4 2009 Jul-Aug Nursing research Nurs Res A meta-analysis of interventions to promote mammography among ethnic minority women. 246-54 10.1097/NNR.0b013e3181ac0f7f Although many studies have been focused on interventions designed to promote mammography screening among ethnic minority women, few summaries of the effectiveness of the interventions are available (...) . The aim of this study was to determine the effectiveness of the interventions for improving mammography screening among asymptomatic ethnic minority women. A meta-analysis was performed on intervention studies designed to promote mammography use in samples of ethnic minority women. Random-effects estimates were calculated for interventions by measuring differences in intervention and control group screening rates postintervention. The overall mean weighted effect size for the 23 studies was 0.078 (Z

EvidenceUpdates2009 Full Text: Link to full Text with Trip Pro

86. Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data

Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data 19401569 2009 04 29 2009 05 28 2016 11 25 1527-1315 251 2 2009 May Radiology Radiology Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data. 347-58 10.1148/radiol.2512081235 To (a) compare the performance of full-field digital mammography (FFDM), using hard-copy image (...) reading, with that of screen-film mammography (SFM) within a UK screening program (screening once every 3 years) for women aged 50 years or older and (b) conduct a meta-analysis of published findings along with the UK data. The study complied with the UK National Health Service Central Office for Research Ethics Committee guidelines; informed patient consent was not required, since analysis was carried out retrospectively after data anonymization. Between January 2006 and June 2007, a London

EvidenceUpdates2009

87. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines

Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Ahern CH, Shen Y Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The aim was to assess the cost-effectiveness of breast cancer screening strategies that combined mammography and clinical breast examination. The authors suggested that, due to its superior cost-effectiveness, the strategy of mammography and clinical breast examination every two years, and given

NHS Economic Evaluation Database.2009

88. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland

Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, de Koning HJ Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) that for organised screening. There were a few limitations to the study, but the methods and results were presented well, and the authors’ conclusions appear to be appropriate. Type of economic evaluation Cost-effectiveness analysis, cost-utility analysis Study objective The objective was to compare the cost-effectiveness of alternative screening programmes for breast cancer in women aged 50 to 69 years in Switzerland. Interventions Organised biennial mammography screening was compared with opportunistic

NHS Economic Evaluation Database.2009

89. A meta-analysis of interventions to promote mammography among ethnic minority women

A meta-analysis of interventions to promote mammography among ethnic minority women A meta-analysis of interventions to promote mammography among ethnic minority women A meta-analysis of interventions to promote mammography among ethnic minority women Han HR, Lee JE, Kim J, Hedlin HK, Song H, Kim MT CRD summary The authors concluded that findings suggested a need for increased use of a therapy-based tailored approach with enhancement of access to improve mammography screening rates among women (...) from ethnic minorities. The review was generally well-conducted, but the conclusions were based on subgroup analyses of diverse studies of uncertain quality and should be interpreted with caution. Authors' objectives To evaluate the effectiveness of interventions aimed at increasing mammography screening rates in asymptomatic ethnic minority women in USA. Searching MEDLINE, CINAHL, PsycINFO and Web of Science were searched for studies published in English from 2000 to August 2008. Key words were

DARE.2009

90. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends Jorgensen K J, Gotzsche P C CRD summary This review found that an increase in breast cancer incidence was closely related to introduction of screening, and concluded that one (...) by the data presented, but it is unclear whether the conclusion about one in three cancers being overdiagnosed is reliable. Implications of the review for practice and research The authors did not state any implications for practice or research. Funding Not stated. Bibliographic details Jorgensen K J, Gotzsche P C. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009; 339:b2587 PubMedID DOI Original Paper URL Indexing Status Subject indexing

DARE.2009

91. Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data

Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data Vinnicombe S, Pinto Pereira SM, McCormack VA, Shiel S, Perry N, dos Santos (...) Silva IM CRD summary This review concluded that within a routine screening programme, full-field digital mammography with hard-copy reading performed at least as well as screen-film mammography for breast cancer detection. Multiple issues with the methodology and reporting of the review process mean that the reliability of these conclusions is unclear. Authors' objectives To compare full-field digital mammography using hard-copy image reading with screen-film mammography within a three-yearly

DARE.2009

92. Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis

Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis Noble M, Bruening W, Uhl S, Schoelles K CRD summary This review assessed the diagnostic performance of computer-aided detection mammography for breast cancer screening. No conclusions were (...) drawn for diagnostic performance. The authors' statement that the benefits and risks of computer-aided detection should be considered carefully as data were not available to determine whether the incremental cancer detection rate was associated with changes in patient outcomes was a reasonable interpretation. Authors' objectives To assess the diagnostic performance of computer-aided detection mammography in screening for breast cancer. Searching Seventeen bibliographic databases, including MEDLINE

DARE.2009

93. [Diagnostic performance of digital mammography in breast cancer screening]

[Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Marquez Cruz MD, Marquez Calderon S Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Marquez Cruz MD, Marquez Calderon S. Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama. [Diagnostic performance of digital mammography in breast cancer screening] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/09. 2009 Authors' conclusions No important

Health Technology Assessment (HTA) Database.2009

94. Premedication to Reduce Discomfort during Screening Mammography

Premedication to Reduce Discomfort during Screening Mammography 18647845 2008 08 19 2008 09 15 2013 11 21 1527-1315 248 3 2008 Sep Radiology Radiology Premedication to reduce discomfort during screening mammography. 765-72 10.1148/radiol.2482071490 To test the hypothesis that premedication with acetaminophen, ibuprofen, and/or 4% lidocaine gel would decrease discomfort and improve satisfaction with screening mammography in women who expect a higher level of discomfort. In this HIPAA-compliant (...) , institutional review board-approved, prospective, double-blinded, placebo-controlled clinical trial, 418 women aged 32-89 years who expected substantial discomfort with screening mammography were randomly divided to receive premedication with acetaminophen, ibuprofen, and/or 4% lidocaine gel. Subjects provided informed written consent. The primary outcome was discomfort. Secondary outcomes were satisfaction and plans for future mammography on the basis of discomfort. Subjects completed structured

EvidenceUpdates2008

95. Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries

Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries Review: adequately randomised trials showed that mammography screening did not significantly reduce breast cancer, cancer, or all cause mortality but increased breast surgeries | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society (...) Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: adequately randomised trials showed that mammography screening did not significantly reduce breast

Evidence-Based Nursing (Requires free registration)2008

96. (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007).

(1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:006083 This guideline summary

American Cancer Society2008

97. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy

Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy 18299491 2008 02 26 2008 04 24 2016 11 24 0003-9926 168 4 2008 Feb 25 Archives of internal medicine Arch. Intern. Med. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. 370-7; quiz 345 10.1001/archinternmed.2007.123 The effect of combined hormone therapy on breast cancer detection is not established. We examined the effect of combined hormone therapy (...) on breast cancer detection in the Women's Health Initiative trial, which randomized 16,608 postmenopausal women to receive conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d) or placebo. Mammography and breast examinations were performed at baseline and annually per protocol, with breast biopsies based on clinical findings. The effects of conjugated equine estrogens plus medroxyprogesterone acetate on breast cancer detection was determined throughout 5.6 years

EvidenceUpdates2008

98. Effect of cost sharing on screening mammography in medicare health plans.

Effect of cost sharing on screening mammography in medicare health plans. BACKGROUND: Policies that increase patients' share of health care expenses decrease the use of discretionary health services but also may reduce the use of important preventive care such as mammography. METHODS: We reviewed coverage for mammography within 174 Medicare managed-care plans from 2001 through 2004. Among 550,082 individual-level observations for 366,475 women between the ages of 65 and 69 years, we compared (...) rates of biennial breast-cancer screening in plans requiring cost sharing for mammography with screening rates in plans with full coverage. We also performed a longitudinal analysis of screening rates in plans that changed from full coverage to cost sharing for mammography as compared with rates in matched control plans that did not institute cost sharing. RESULTS: The number of plans with cost sharing for mammography, which we defined as requiring a copayment of more than $10 or coinsurance of more

NEJM2008

99. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost

Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost (...) with ultrasound (US) in self-referring women with dense breasts and a negative report on mammography. US detected early-stage cancers in women with mammography-negative dense breasts, especially in women younger than 50 years, but with substantial financial implications. Overall, the reporting of the clinical data was satisfactory. However, there was little information on the cost analysis and the issue of uncertainty was not addressed, so caution is required when interpreting the authors’ conclusions. Type

NHS Economic Evaluation Database.2008

100. Over-diagnosis from mammography screening

Over-diagnosis from mammography screening Cancer Australia | A national government agency working to reduce the impact of cancer on all Australians ") //--> ") //--> Search form Search News Featured Sites Featured Video Visit our channel Video of Introduction to the Statement View the video transcript ( ) Cancer types A - Z list of cancer types In Focus Copyright © 2017 - Cancer Australia

National Breast and Ovarian Cancer Centre2008